Friday, August 8, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Title Precision BioSciences Partner Receives Approval to Expand Clinical Trial for ARCUS Gene Editing Program Targeting OTC Deficiency

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
Biotechnology Market Capitalization
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Precision BioSciences has recently revealed that iECURE, its partner, has been granted approval by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to broaden the Phase 1/2 clinical trial for the ARCUS Gene Editing Program targeting OTC Deficiency. This milestone approval signifies a major advancement in the realm of gene editing research for OTC deficiency, with the ultimate goal of providing groundbreaking treatment solutions for individuals affected by this condition.

Date: March 6, 2024

Precision BioSciences Inc. (DTIL) Stock Performance Analysis: March 6, 2024

On March 6, 2024, the stock performance of Precision BioSciences Inc. (DTIL) was a topic of interest for investors as the company’s shares experienced some notable movements. According to data from CNN Money, DTIL was trading near the bottom of its 52-week range and below its 200-day simple moving average. This indicates that the stock may be in a bearish trend, as it is trading below its long-term average price.

On that particular day, the price of DTIL shares had decreased by $0.29 since the market last closed, representing a 2.32% drop from the previous day’s closing price of $12.21. This decline may have been concerning for some investors, as it suggests a negative sentiment towards the stock. However, there was some positive news for DTIL as well, as the stock had risen by $0.41 in pre-market trading. This uptick in price could indicate that some investors were optimistic about the company’s prospects, leading to increased buying activity before the market opened.

Overall, the mixed performance of DTIL on March 6th highlights the volatility and uncertainty that can be present in the stock market. Investors should always conduct thorough research and analysis before making any investment decisions, especially when a stock is exhibiting significant price movements. It will be interesting to see how DTIL continues to perform in the coming days and whether the stock can sustain its pre-market gains.

DTIL Stock Reports Significant Decline in Financial Performance in 2024

On March 6, 2024, DTIL stock experienced a significant decline in its financial performance compared to the previous year and the last quarter. According to data from CNN Money, the company reported total revenue of $25.10 million over the past year, which represents a 78.28% decrease from the previous year. In the most recent quarter, DTIL reported total revenue of $13.12 million, reflecting a 33.7% decrease from the previous quarter.

The net income of DTIL also saw a substantial decline, with a reported net loss of $111.64 million over the past year, representing a 264.8% decrease from the previous year. However, in the last quarter, the net loss improved slightly to $12.11 million, showing a 1.84% increase from the previous quarter.

Furthermore, the earnings per share (EPS) of DTIL also took a hit, with an EPS of -$38.10 over the past year, reflecting a 143.57% decrease from the previous year. In the last quarter, the EPS improved slightly to -$4.30, but still represented a 37.67% decrease from the previous quarter.

Tags: DTIL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance analyst

Analyst Maintains Outperform Rating and Raises Price Target for Cannae Holdings

Cyber-security-technology

Consistent Perform Ratings for ChargePoint Holdings Inc despite Recent Developments

Applied Therapeutics Reports Disappointing Q4 Financial Results

Recommended

ALB stock news

Allspring Global Investments Increases Stake in Automotive Parts Company, Douglas Dynamics Inc.

2 years ago
Technology Robotics Markets and money

Exela Technologies Inc and XBP Europe Launch Reaktrai Revolutionizing Cybersecurity and Data Management with AI

2 years ago

Positive Outlook and Increased Price Target for Corteva

2 years ago
Alternative Energy Markets and money (1)

Ecopetrols Commitment to Thorough Evaluation and Reliable Results for Arauca 8 Well

2 years ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN AVGO BA C CCL CELH COIN COST CRWD CTVA DELL DFS DIS DLR DLTR DWAC GM GRFS IBM INTC JPM KSS LLY META MSFT NFLX NVDA NVO ORCL PARA PLTR PLUG QCOM SMCI TGT TSLA UNH VZ
No Result
View All Result

Highlights

Lucid Group Stock: Turbulence Amid Policy Shifts and Uber Deal

Walt Disney Stock: Marvel Woes Offset by NFL Deal

Fresenius Stock: Mixed Q2 Results Amid Margin Pressures

Beiersdorf Stock: Nivea’s Glow Fades as Forecasts Dim

ABN Amro Stock: Profit Dip Amid Strong Capital Moves

Vonovia Stock: Strong Recovery Fuels Optimism

Trending

Snap Stock
Stocks

Snap Stock: Turmoil Amid Advertising Woes

by Dieter Jaworski
August 6, 2025
0

Snap Inc.'s stock has become a battleground for Wall Street analysts following disappointing Q2 results, with price...

DHL Stock

DHL Stock: Rollercoaster Ride Amid Strong Earnings

August 6, 2025
Klöckner Stock

Klöckner Stock: Turnaround Amid Market Volatility

August 6, 2025
Lucid Group Stock

Lucid Group Stock: Turbulence Amid Policy Shifts and Uber Deal

August 6, 2025
Walt Disney Stock

Walt Disney Stock: Marvel Woes Offset by NFL Deal

August 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Bechtle Stock: Mixed Q2 Results Amid Margin Pressures August 8, 2025
  • Desert Gold Ventures Stock: Mali Gold Project Sparks Investor Optimism August 8, 2025
  • Sony Stock: Defies Tariff Fears with Stellar Earnings August 8, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com